Finding Fault? Exploring Legal Duties to Return Incidental Findings in Genomic Research
Elizabeth R Pike1, Karen H Rothenberg2, Benjamin E Berkman3
1Senior Policy and Research Analyst, Presidential Commission for the Study of Bioethical Issues. At the time of this work, Elizabeth Pike was a post-doctoral fellow in the Department of Bioethics at the National Institutes of Health. This Article was written by Elizabeth Pike in her private capacity. No official support or endorsement by the Presidential Commission for the Study of Bioethical Issues or the Department of Health and Human Services is intended, nor should it be inferred.
Researchers face ethical and legal challenges returning incidental findings (IFs) from whole-genome sequencing. Clear informed consent is proposed to define disclosure policies and mitigate legal risks for researchers.
Area of Science:
- Genomics
- Bioethics
- Medical Law
Background:
- Whole-genome sequencing (WGS) in research offers health advances but generates incidental findings (IFs).
- Ethical obligations for returning IFs are debated, leading to inconsistent practices.
- Inconsistent return of IFs raises concerns about legal liability for researchers.
Purpose of the Study:
- To assess potential legal claims arising from a researcher's failure to return IFs.
- To explore the legal ramifications of ethical obligations to return IFs.
- To advocate for a clearer standard regarding the disclosure of IFs in research.
Main Methods:
- Analysis of potential tort claims against researchers for non-disclosure of IFs.
- Examination of the evolving legal landscape concerning genetic and genomic research.
- Review of existing ethical guidance and customary practices related to IFs.
Main Results:
- The potential for tort liability for failing to return IFs remains uncertain.
- Legal duty for researchers is less defined than in clinical care, complicating liability assessment.
- Current practices for returning IFs are inconsistent, lacking clear legal precedent.
Conclusions:
- A clearer, ethically sound standard is needed for managing IFs in WGS research.
- Requiring disclosure of the IFs return policy in informed consent is advocated.
- This approach enhances participant autonomy, clarifies researcher obligations, and promotes consistent legal guidance.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Legal Guidelines for Documentation
Genomics
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...


